As of 2026-03-24, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -0.04 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Evelo Biosciences Inc is -4,337,710.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 4,337,710.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.04 - -0.04 | -0.04 | -4,337,710.00% |
| P/E | (0.16) - (0.19) | (0.18) | -17567424.1% |
| DDM - Stable | (0.00) - (0.00) | (0.00) | -4795.1% |
| DDM - Multi | (0.00) - (0.00) | (0.00) | -4621.9% |
| Market Cap (mil) | 0.01 |
| Beta | -4.09 |
| Outstanding shares (mil) | 9,491.40 |
| Enterprise Value (mil) | 16.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 17,161.49% |
| Cost of Debt | 5.00% |
| WACC | 8.72% |